Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Synovial fluid lipid membranes and associated extracellular components, such as surface-active phospholipids (SAPL), hyaluronic acid, and lubricin, constitute a critical functional system for maintaining joint health and mobility. These components organize into complex layers on the articular cartilage surface and within the synovial fluid to provide boundary lubrication, which significantly reduces friction and mechanical wear during joint movement (Jay & Waller, 2014). The primary lipid component, dipalmitoylphosphatidylcholine (DPPC), acts as a surfactant that coats the cartilage, while hyaluronic acid provides viscosity and lubricin facilitates the sliding of surfaces under high loads (Hills, 2002). In degenerative conditions like osteoarthritis, the concentration and structural integrity of these lipids and proteins are compromised, leading to increased joint friction, inflammation, and progressive cartilage destruction (Kretzer et al., 2012). Therapeutic strategies targeting this system include viscosupplementation with exogenous hyaluronic acid and the development of synthetic lipid-based lubricants to restore the protective boundary layer. These interventions aim to alleviate pain and improve joint function by mimicking the natural lubricating properties of the synovial environment.
Restoration of the boundary lubrication layer and enhancement of synovial fluid viscosity to reduce mechanical friction and wear on articular surfaces.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Synovial fluid lipid membrane and associated extracellular components (SAPL).